DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2021.


  • Second quarter revenue increased to $61.5 million in fiscal 2021 from $54.8 million in fiscal 2020, reflecting the acquisition of Irving Burton Associates (“IBA”)
  • Operating margins rose to 7.5% in the current year second quarter from 7.0% in the prior-year period
  • Earnings were $2.6 million, or $0.19 per diluted share, for the fiscal 2021 second quarter versus $2.1 million, or $0.16 per diluted share, for the second quarter of fiscal 2020
  • After the end of the quarter, in April 2021, the Company announced it had won the Consolidated Mail Outpatient Pharmacy ("CMOP") logistics recompete with U.S. Department of Veterans Affairs ("VA"), worth approximately $202 million over five years
  • Contract backlog was $608.7 million as of March 31, 2021, excluding the subsequent CMOP logistics award of approximately $202 million.

Management Discussion“We continued to see positive trends this quarter impacting all aspects of our performance, supporting our confidence for the year ahead,” said DLH President and Chief Executive Officer Zach Parker. “Revenue rose 12% versus the comparable period in 2020, and we reported improved operating margins of 7.5% along with earnings of $0.19 per share. We remain focused on de-levering the Company further as the year progresses and affirm our prior estimate of a debt balance of $50 to $52 million at fiscal year end. We’re actively bidding on numerous other opportunities within our core markets, underscoring our positive outlook for the remainder of fiscal 2021.

"In April, we announced that the VA had awarded us a follow-on contract to provide medical logistics for its CMOP program, which we’ve now managed for over two decades. The VA’s confidence in our ability to continue providing this invaluable service – made even more important by the pandemic – speaks volumes to the capabilities of our staff and demonstrates our commitment to this agency. We are honored by the award of this contract, which includes a base period of one year and four one-year options, providing enhanced revenue visibility and stability."

Results for the Three Months Ended March 31, 2021Revenue for the second quarter of fiscal 2021 was $61.5 million versus $54.8 million in the prior-year period. The increase was due principally to the Company’s IBA acquisition, completed September 30, 2020, which added approximately $7.4 million in revenue; partially offset by reductions in travel-related program revenue compared to the prior-year period. The reduction in travel-related program revenue was primarily due to the COVID-19 pandemic.

Income from operations was $4.6 million for the quarter versus $3.8 million in the prior-year period and, as a percent of revenue, the Company reported an operating margin of 7.5% in fiscal 2021 versus 7.0% in fiscal 2020. The current year performance reflects increased revenue contribution from time and materials programs, which generally yield stronger returns than cost reimbursable contracts, and lower general and administrative ("G&A") expenses, partially offset by higher depreciation and amortization. Interest expense in the quarter increased to $1.0 million, versus $0.9 million for the three months ended March 31, 2020, due to higher outstanding debt levels, reflecting the acquisition of IBA. Income before taxes was $3.6 million for the quarter versus $2.9 million in fiscal 2020, representing 5.9% and 5.3% of revenue, respectively, for each period.

For the three months ended March 31, 2021 and 2020, respectively, DLH recorded a $1.0 million and $0.9 million provision for tax expense. The Company reported net income of approximately $2.6 million, or $0.19 per diluted share, for the second quarter of fiscal 2021 versus $2.1 million, or $0.16 per diluted share, for the second quarter of fiscal 2020. As a percent of revenue, net income was 4.2% for the second quarter of fiscal 2021 versus 3.7% for the prior year period.

On a non-GAAP basis, EBITDA for the three months ended March 31, 2021 was approximately $6.6 million versus $5.6 million in the prior-year period, or 10.8% and 10.2% of revenue, respectively.

Key Financial IndicatorsFiscal year to date, DLH has generated $6.1 million in operating cash, and has paid down $7.2 million of its secured loan facility. The Company anticipates strong operating cash flow for the remainder of the fiscal year and intends to continue using cash to make debt prepayments when possible.

As of March 31, 2021, the Company had cash and cash equivalents of $0.4 million and debt outstanding under its credit facility of $62.8 million, versus cash of $1.4 million and debt outstanding of $70.0 million as of September 30, 2020.

At March 31, 2021, total backlog was approximately $608.7 million, including funded backlog of approximately $84.6 million, and unfunded backlog of $524.1 million. The backlog excluded the April CMOP logistics contract award of approximately $202 million.

Conference Call and Webcast DetailsDLH management will discuss second quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 11:00 AM Eastern Time Thursday, May 6, 2021. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.

A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 10155504.

About DLHDLH delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the outbreak of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the risk that we will not realize the anticipated benefits of our recent or any future acquisition; the challenges of managing larger and more widespread operations resulting from our recent acquisition; contract awards in connection with re-competes for present business and/or competition for new business; compliance with new bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations our recent acquisition and of any future acquisitions; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.


Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com


    Three Months Ended   Six Months Ended
    March 31,   March 31,
    2021   2020   2021   2020
Revenue   $ 61,506     $ 54,798     $ 119,358     $ 107,036  
Cost of Operations:                
Contract costs   48,722     42,941     94,727     84,281  
General and administrative costs   6,135     6,260     12,285     12,174  
Depreciation and amortization   2,029     1,760     4,091     3,619  
Total operating costs   56,886     50,961     111,103     100,074  
Income from operations   4,620     3,837     8,255     6,962  
Interest expense, net   1,004     906     2,084     1,846  
Income before income taxes   3,616     2,931     6,171     5,116  
Income tax expense   1,049     855     1,790     1,488  
Net income   $ 2,567     $ 2,076     $ 4,381     $ 3,628  
Net income per share - basic   $ 0.20     $ 0.17     $ 0.35     $ 0.30  
Net income per share - diluted   $ 0.19     $ 0.16     $ 0.32     $ 0.28  
Weighted average common shares outstanding                
Basic   12,544     12,299     12,521     12,193  
Diluted   13,570     13,003     13,568     12,886  

DLH HOLDINGS CORP.CONSOLIDATED BALANCE SHEETS(Amounts in thousands except par value of shares)

    March 31,2021   September 30,2020
Current assets:        
Cash and cash equivalents   $ 420     $ 1,357  
Accounts receivable   41,675     32,541  
Other current assets   3,469     3,499  
Total current assets   45,564     37,397  
Equipment and improvements, net   2,593     3,339  
Operating lease right-of-use assets   21,055     22,427  
Deferred taxes, net       37  
Goodwill   65,643     67,144  
Intangible assets, net   50,762     52,612  
Other long-term assets   539     606  
Total assets   $ 186,156     $ 183,562  
Current liabilities:        
Debt obligations - current, net of deferred financing costs   $ 3,124     $ 6,727  
Operating lease liabilities - current   2,130     2,045  
Accrued payroll   12,012     10,611  
Accounts payable, accrued expenses, and other current liabilities   30,824     28,578  
Total current liabilities   48,090     47,961  
Long-term liabilities:        
Deferred taxes, net   1,475      
Debt obligations - long term, net of deferred financing costs   57,199     60,544  
Operating lease liabilities - long-term   20,499     21,620  
Total long-term liabilities   79,173     82,164  
Total liabilities   127,263     130,125  
Shareholders' equity:        
Common stock, $0.001 par value; authorized 40,000 shares; issued and outstanding 12,545 and 12,404 at March 31, 2021 and September 30, 2020, respectively   13     12  
Additional paid-in capital   86,942     85,868  
Accumulated deficit   (28,062 )   (32,443 )
Total shareholders’ equity   58,893     53,437  
Total liabilities and shareholders' equity   $ 186,156     $ 183,562  


    Six Months Ended
    March 31,
    2021   2020
Operating activities        
Net income   $ 4,381     $ 3,628  
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization expense   4,091     3,619  
Amortization of deferred financing costs   413     374  
Stock based compensation expense   844     384  
Deferred taxes, net   1,512     1,258  
Gain from lease modification       (121 )
Changes in operating assets and liabilities        
Accounts receivable   (9,134 )   (11,722 )
Other current assets   30     (1,211 )
Accrued payroll   1,401     1,913  
Accounts payable, accrued expenses, and other current liabilities   2,245     2,280  
Other long-term assets/liabilities   336     260  
Net cash provided by operating activities   6,119     662  
Investing activities        
Business acquisition adjustment, net of cash acquired   59      
Purchase of equipment and improvements   (53 )   (141 )
Net cash provided by (used in) investing activities   6     (141 )
Financing activities        
Borrowing on revolving line of credit, net       2,000  
Repayment of senior debt   (7,250 )   (3,000 )
Payment of deferred financing costs   (43 )   (3 )
Repurchased shares of common stock       (211 )
Proceeds from issuance of common stock upon exercise of options   231     27  
  Net cash used in financing activities   (7,062 )   (1,187 )
Net change in cash and cash equivalents   (938 )   (666 )
Cash and cash equivalents at beginning of year   1,357     1,790  
Cash and cash equivalents at end of year   $ 420     $ 1,124  
Supplemental disclosures of cash flow information        
Cash paid during the period for interest   $ 1,639     $ 1583  
Cash paid during the period for income taxes   $ 184     $ 409  
Supplemental disclosures of non-cash activity        
Non-cash cancellation of common stock   $     $ 211  

Revenue Metrics

    Six Months Ended
    March 31,   March 31,
    2021   2020
Market Mix:        
Defense/VA   59 %   47 %
Human Services and Solutions   14 %   21 %
Public Health/Life Sciences   27 %   32 %
Contract Mix:        
Time and materials   76 %   70 %
Cost reimbursable   20 %   28 %
Firm fixed price   4 %   2 %
Prime vs Sub:        
Prime   89 %   93 %
Subcontractor   11 %   7 %

Non-GAAP Financial MeasuresThe Company uses EBITDA and EBITDA as a percent of revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA as a percent of revenue is EBITDA for the measurement period divided by revenue for the same period.

These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.

Reconciliation of GAAP net income to EBITDA, a non-GAAP measure:

(amounts in thousands)   Three Months Ended   Six Months Ended
    March 31,   March 31,
    2021   2020   Change   2021   2020   Change
Net income   $ 2,567     $ 2,076     $ 491     $ 4,381     $ 3,628     $ 753  
(i) Interest expense, net     1,004       906       98       2,084     1,846     238  
(ii) Provision for taxes     1,049       855       194       1,790     1,488     302  
(iii) Depreciation and amortization     2,029       1,760       269       4,091     3,619     472  
EBITDA   $ 6,649     $ 5,597     $ 1,052     $ 12,346     $ 10,581     $ 1,765  
Net income as a % of revenue     4.2 %     3.7 %     0.5 %     3.7 %   3.4 %   0.3 %
EBITDA as a % of revenue     10.8 %     10.2 %     0.6 %     10.3 %   9.9 %   0.4 %
Revenue   $ 61,506     $ 54,798     $ 6,708     $ 119,358     $ 107,036     $ 12,322  


Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more DLH Charts.
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more DLH Charts.